Zobrazeno 1 - 10
of 1 123
pro vyhledávání: '"Gulbas, Z."'
Autor:
Montoro J; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Universidad Católica de Valencia, Spain. Electronic address: juanmontorogomez@gmail.com., Boumendil A; European Society for Blood and Marrow Transplantation Lymphoma Working Party, Paris, France., Finel H; European Society for Blood and Marrow Transplantation Lymphoma Working Party, Paris, France., Bramanti S; Department of Oncology/Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Castagna L; Department of Oncology/Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Blaise D; Programme de Transplantation and Therapie Cellulaire, Marseille, France., Dominietto A; UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Kulagin A; RM Gorbacheva Research Institute, Pavlov University, Saint Petersburg, Russia., Yakoub-Agha I; CHU de Lille, University of Lille, Lille, France., Tbakhi A; King Hussein Cancer Centre, Amman, Jordan., Solano C; Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain., Giebel S; The Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Gulbas Z; Anadolu Health Center Avliated John Hopkins, Kocaeli, Gebze, Turkey., López Corral L; Hospital Clínico Salamanca, Salamanca, Spain., Pérez-Simón JA; Servicio de Hematología, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Spain., Díez Martín JL; Hospital Gregorio Marañon, Madrid, Spain., Sanz J; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Farina L; University of Milan. Hematology Division, Fondazione IRCCS Istituto. Nazionale dei Tumori di Milano, Milan, Italy., Koc Y; Medical Park Hospitals, Beylikduzu, Istanbul, Turkey., Socié G; Department of Hematology - BMT, Hematology Transplantation, Paris, France., Arat M; Demiroglu Bilim University Istanbul Florence Nightingale Hospital, Hematopoietic SCT Unit, Istanbul, Turkey., Jurado M; Hospital Virgen De Las Nieves, Granada, Spain., Bermudez A; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Labussière-Wallet H; Centre Hospitalier Lyon Sud, Lyon, France., Villalba M; Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Ciceri F; Hematology and Bone Marrow Transplantation Unit, Milano, Italy., Martinez C; Hematopoietic Stem Cell Transplantation Unit, Hospital Clínic de Barcelona, Institute of Cancer and Blood Diseases, Barcelona, Spain., Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel., Sureda A; Hematology Department. Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d'Investigació Biomèdica de Bellvitge, Universitat de Barcelona, Barcelona, Spain., Glass B; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St. Georg, Hamburg, Germany.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Feb; Vol. 30 (2), pp. 210.e1-210.e14. Date of Electronic Publication: 2023 Dec 01.
Autor:
Birtas Atesoglu E; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Gulbas Z; Division of Hematology, Anadolu Medical Center, Kocaeli, Turkey., Uzay A; Division of Hematology, Acibadem Atakent Hospital, Istanbul, Turkey., Ozcan M; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey., Ozkalemkas F; Department of Internal Medicine, Division of Hematology, Uludag University Medical Faculty, Bursa, Turkey., Dal MS; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital, Ankara, Turkey., Kalyon H; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Akay OM; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey., Deveci B; Division of Hematology, Medstar Hospital, Antalya, Turkey., Bekoz H; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey., Sevindik OG; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey., Toptas T; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey., Yilmaz F; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey., Koyun D; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey., Alkis N; Division of Hematology, Bursa City Hospital, Bursa, Turkey., Alacacioglu I; Department of Internal Medicine, Division of Hematology, Dokuz Eylul University Medical Faculty, Izmir, Turkey., Sonmez M; Department of Internal Medicine, Division of Hematology, Karadeniz Technical University Medical Faculty, Trabzon, Turkey., Yavasoglu I; Department of Internal Medicine, Division of Hematology, Adnan Menderes University Medical Faculty, Aydin, Turkey., Tombak A; Department of Internal Medicine, Division of Hematology, Mersin University Medical Faculty, Mersin, Turkey., Mehtap O; Department of Internal Medicine, Division of Hematology, Kocaeli University Medical Faculty, Kocaeli, Turkey., Kurnaz F; Division of Hematology, Kocaeli Medicalpark Hospital, Kocaeli, Turkey., Yuce OK; Department of Internal Medicine, Division of Hematology, Akdeniz University Medical Faculty, Antalya, Turkey., Karakus V; Division of Hematology, Antalya Research and Training Hospital, Antalya, Turkey., Turgut M; Department of Internal Medicine, Division of Hematology, Ondokuzmayıs University Medical Faculty, Samsun, Turkey., Kurekci DD; Department of Internal Medicine, Division of Hematology, Ondokuzmayıs University Medical Faculty, Samsun, Turkey., Ayer M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey., Keklik M; Department of Internal Medicine, Division of Hematology, Erciyes University Medical Faculty, Kayseri, Turkey., Buyuktas D; Division of Hematology, V.K.V. American Hospital, Istanbul, Turkey., Ozbalak M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey., Ferhanoglu B; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.
Publikováno v:
Hematological oncology [Hematol Oncol] 2023 Oct; Vol. 41 (4), pp. 663-673. Date of Electronic Publication: 2023 May 22.
Autor:
Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli,' Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Thieblemont C; Department of Hemato-Oncology, Hôpital Saint-Louis APHP, Paris, France., Melnichenko V; Department of Medical Oncology, Pirogov National Medical Surgical Center, Moscow, Russia., Bouabdallah K; Department of Hematology and Cellular Therapy, University Hospital, Bordeaux, France., Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, European Reference Network, Warsaw, Poland., Majlis A; Department of Hemato-Oncology, Clinica Alemana de Santiago, Santiago, Chile., Fogliatto L; Department of Clinical Hematology, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil., Garcia-Sancho AM; Department of Hematology, Hospital Universitario de Salamanca, Institute of Biomedical Research of Salamanca, Centro de Investigación Biomédica en Red Cáncer, Salamanca, Spain., Christian B; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Gulbas Z; Department of Hematologic Oncology, Anadolu Medical Center, Gebze, Turkey., Özcan M; Department of Hematology and Bone Marrow Transplantation Unit, Ankara University School of Medicine, Ankara, Turkey., Perini GF; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Ghesquieres H; Department of Clinical Hematology, Lyon-Sud Hospital Center, Lyon, France., Shipp MA; Department of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA., Thompson S; Department of Medical Oncology, Merck & Co, Inc, Rahway, NJ., Chakraborty S; Department of Medical Oncology, Merck & Co, Inc, Rahway, NJ., Marinello P; Department of Medical Oncology, Merck & Co, Inc, Rahway, NJ., Armand P; Department of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood [Blood] 2023 Jul 13; Vol. 142 (2), pp. 141-145.
Publikováno v:
Journal of Stem Cells and Regenerative Medicine, Vol 7, Iss 2, Pp 87-89 (2011)
IntroductionHeart failure is a major cardiovascular health problem. Coronary artery disease is the leading cause of congestive heart failure (CHF) [1]. Cardiac transplantation remains the most effective long-term treatment option, however is limited
Externí odkaz:
https://doaj.org/article/3631343bc83f4523ae5d9fb7a5426daa
Autor:
Ye Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China., Labopin M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France., Chen J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Gulbas Z; Anadolu Medical Center Hospital Bone Marrow Transplantation Department, Kocaeli, Turkey., Zhang X; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China., Koc Y; Medicana International Hospital Istanbul, Bone Marrow Transplant Unit, Istanbul, Turkey., Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France., Ciceri F; Ospedale San Raffaele S.R.L., Haematology and BMT, Milan, Italy., Polge E; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France., Houhou M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France., Li L; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China., Luo Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China., Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China. hehuangyu@126.com., Mohty M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France. mohamad.mohty@inserm.fr.; Department of Hematology and Cell Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. mohamad.mohty@inserm.fr.; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France. mohamad.mohty@inserm.fr., Gorin NC; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France. gorinclaude@gmail.com.; Department of Hematology and Cell Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. gorinclaude@gmail.com.; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France. gorinclaude@gmail.com.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2023 Mar 18; Vol. 16 (1), pp. 25. Date of Electronic Publication: 2023 Mar 18.
Autor:
Bekoz, H, Ozbalak, M, Karadurmus, N, Paydas, S, Turker, A, Toptas, T, Tuglular, TF, Altuntas, F, Cakar, MK, Sonmez, M, Gulbas, Z, Demir, N, Kaynar, L, Yildirim, R, Karadogan, I, Arat, M, Kapucu, I, Aslan, NA, Ozkocaman, V, Turgut, M, Yuksel, MK, Ozcan, M, Hacioglu, SK, Barista, I, Demirkaya, M, Saydam, G, Toprak, SK, Yilmaz, M, Demirkol, O, Ferhanoglu, B
Classical Hodgkin lymphoma (cHL) is considered a curable disease; however, in approximately one-third of the responding patients, the disease relapses following completion of therapy. One of the drugs that have been approved for the treatment of rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::6e8faca722dab9d42fc9ee929f56c69e
Autor:
Beksac, M, Aydin, Y, Goker, H, Turgut, M, Besisik, SK, Cagirgan, S, Tuglular, T, Vural, F, Yagci, M, Alacacioglu, I, Aytan, P, Goksoy, HS, Gulbas, Z, Gunes, AK, Gurkan, E, Hacioglu, SK, Karti, SS, Kaynar, L, Ozdogu, H, Paydas, S, Solmaz, S, Sonmez, M, Tekgunduz, E, Yildirim, R, Ilhan, O
The present study investigated the efficacy and safety profile of daratumumab monotherapy in 42 patients with relapsed refractory multiple myeloma through a Turkish early access program. The current findings have confirmed the efficacy of daratumumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::24a32a3cac281d399e675f138df50667
Autor:
Meric N; Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Kütahya University of Health Sciences, Kütahya, Turkey. Electronic address: nesli7726@gmail.com., Parmaksız A; Faculty of Medicine, Istanbul Health and Technology University, Istanbul, Turkey., Gulbas Z; Anadolu Health Center, Bone Marrow Transplantation Center, Kocaeli, Turkey.
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2023 Feb; Vol. 30 (1), pp. 82-86. Date of Electronic Publication: 2022 Aug 17.
Autor:
Paksoy N; Department of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Turkey., Ferhatoglu F; Department of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Turkey., Dogan İ; Department of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Turkey., Khanmammadov N; Department of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Turkey., Iribas Celik A; Department of Radiation Oncology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey., Gulbas Z; Department of Hematology, Anadolu Medical Center, Gebze, Turkey., Başaran M; Department of Medical Oncology, İstanbul University Institute of Oncology, İstanbul, Turkey.
Publikováno v:
Medicine [Medicine (Baltimore)] 2022 Dec 09; Vol. 101 (49), pp. e32213.
Autor:
Ruggeri A; Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy; Eurocord, Hôpital Saint Louis and IUH University Paris VII, Paris, France. Electronic address: annalisaruggeri80@hotmail.com., Galimard JE; Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris, France., Labopin M; Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris, France., Rafii H; Eurocord, Hôpital Saint Louis and IUH University Paris VII, Paris, France., Blaise D; Institut Paoli Calmettes, Marseille, France., Ciceri F; Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy., Diez-Martin JL; Hematology Department, Hospital GU Gregorio Marañon, Instituto de Investigación Sanitaria Gregorio Marañon, Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Cornelissen J; Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands., Chevallier P; Hematology Service, Hôtel Dieu, Nantes, France., Sanchez-Guijo F; Hematology Department, University Hospital of Salamanca, USAL-IBSAL, Salamanca, Spain., Nicholson E; Department of Haematology, Royal Marsden Hospital, London, United Kingdom., Castagna L; Humanitas Cancer Center, Rozzano, Italy., Forcade E; CHU Bordeaux, Hôpital Haut-leveque, Bordeaux, France., Kuball J; Department of Hematology,University Medical Centre, Utrecht, the Netherlands., Rovira M; BMT Unit, Department of Hematology, Institute of Hematology & Oncology, Hospital Clinic, Institut Josep Carreras, Barcelona, Spain., Koc Y; Medicana International, Istanbul, Turkey., Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom., Gulbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Turkey., Vydra J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Baron F; Department of Hematology, CHU of Liège, Liège, Belgium., Sanz J; Hospital Universitario y Politécnico La Fe, Valencia, Spain and CIBERONC, Madrid, Spain., Spyridonidis A; University Hospital of Patras, Patras, Greece., Savani B; Vanderbilt University Medical Center, Nashville, Tennessee., Gluckman E; Eurocord, Hôpital Saint Louis and IUH University Paris VII, Paris, France; Monacord, Centre Scientifique de Monaco, Monaco., Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Aviv University, Ramat Gan, Israel., Mohty M; Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris, France; INSERM, UMR 938, Paris, France.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2022 Oct; Vol. 28 (10), pp. 710.e1-710.e10. Date of Electronic Publication: 2022 Jul 11.